Prognostic significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting response to neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer: a prospective study
Authors:
- 20 December 2025
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 318, 114901
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Symptoms of Women With High-Risk Early-Stage Ovarian CancerObstetrics & Gynecology, 2022
- Elevated platelet lymphocyte ratio is a poor prognostic factor in advanced epithelial ovarian cancerJournal of Gynecology Obstetrics and Human Reproduction, 2021
- The role of changes in systemic inflammatory response markers during neoadjuvant chemotherapy in predicting suboptimal surgery in ovarian cancerCurrent Problems in Cancer, 2020
- Neutrophil‐to‐lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapyInternational Journal of Gynecology & Obstetrics, 2019
- Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical CancerScientific Reports, 2019
- Molecular Diagnostics in Colorectal CarcinomaClinics In Laboratory Medicine, 2018
- Neutrophil: Lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasisJournal of Surgical Oncology, 2018
- Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancerScientific Reports, 2017
- Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and NutritionBritish Journal of Cancer, 2011
- BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma casesCancer, 2005